Effect of Pioglitazone on Nonalcoholic Fatty Liver Disease in Morbid Obese Patients; a Randomized Controlled Trial.

Masoud Sayadishahraki,Sam Mirfendereski,Ali Kachuei,Aryan Rafiee Zadeh,Abbas Mirghaderi

Advanced biomedical research（2023）

引用 1|浏览4

暂无评分

摘要

The use of pioglitazone for 4 months resulted in improvements in fatty liver stage, liver size, BMI, FBS, and lipid profile. These data show the effectiveness of pioglitazone in NAFLD.

查看译文

关键词

Bariatric surgery,NAFLD,RCT,fatty liver disease,obesity,pioglitazone

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要